Characterization of vitreoretinal interface disorders using OCT in the interventional phase 3 trials of ocriplasmin.
暂无分享,去创建一个
F. Folgar | C. Toth | G. Jaffe | S. Stinnett | S. Pakola | R. Burns | F. C. Decroos | Cynthia S. Heydary
暂无分享,去创建一个
F. Folgar | C. Toth | G. Jaffe | S. Stinnett | S. Pakola | R. Burns | F. C. Decroos | Cynthia S. Heydary